Guaifenesin + Dextromethorphan Hydrobromide

15 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

670.0%

Death Rate

Active Ingredients

Guaifenesin + Dextromethorphan Hydrobromide

Administration Routes

UnknownOral

Species Affected

Dog 15

Most Affected Breeds

Shepherd Dog - Australian 6

Crossbred Canine/dog 3

Hound (unspecified) 1

Beagle 1

Retriever - Labrador 1

Pit Bull 1

Poodle - Standard 1

Lhasa Apso 1

Most Reported Reactions

Nasal discharge 7

Cough 4

Lethargy (see also Central nervous system depression in Neurological) 4

Pneumonia 4

Lack of efficacy - NOS 4

Elevated alanine aminotransferase (ALT) 3

Elevated serum alkaline phosphatase (ALP) 3

Cough, productive 3

Sneezing 3

Sinus congestion 3

Neutrophilia 3

Vomiting 2

Outcome Breakdown

Ongoing

7 (46.7%)

Outcome Unknown

6 (40.0%)

Recovered/Normal

1 (6.7%)

Euthanized

1 (6.7%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.